Book section · January 1, 2023
Regulatory changes in the United States and Europe have stimulated major pediatric clinical trials of >18 different antihypertensive agents over the last two decades. As pediatric hypertension trials have become more common, trial designs have been refined ...
Full textCite
https://orcid.org/0000-0003-3426-1789